NYSE:WAT - Waters Stock Price, News, & Analysis

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters announced that its board has authorized a share repurchase plan on Tuesday, April 24th 2018, which permits the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 18.2% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its shares are undervalued.

Waters Co. (NYSE:WAT) posted its quarterly earnings data on Wednesday, January, 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.64 by $0.23. The medical instruments supplier earned $715 million during the quarter, compared to analysts' expectations of $702.74 million. Waters had a return on equity of 34.18% and a net margin of 24.54%. The company's quarterly revenue was up 4.0% on a year-over-year basis. During the same period last year, the company posted $2.51 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, April 23rd 2019. View Earnings Estimates for Waters.

Waters updated its FY19 earnings guidance on Wednesday, January, 23rd. The company provided earnings per share (EPS) guidance of $9.20-9.45 for the period, compared to the Thomson Reuters consensus estimate of $9.18. Waters also updated its FY 2019 guidance to $9.20-9.45 EPS.

14 brokerages have issued 12-month target prices for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' share price to reach $205.3715 in the next year. This suggests that the stock has a possible downside of 16.3%. View Analyst Price Targets for Waters.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 2 sell ratings, 11 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Media headlines about WAT stock have been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Waters earned a daily sentiment score of 1.4 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Some companies that are related to Waters include QUALCOMM (QCOM), Intuit (INTU), Dell Technologies (DVMT), T-Mobile Us (TMUS), Baidu (BIDU), KDDI CORP/ADR (KDDIY), Vodafone Group (VOD), America Movil SAB de CV ADR Series L (AMX), Infosys (INFY), Micron Technology (MU), ServiceNow (NOW), Orange (ORAN), Dell (DELL), Cognizant Technology Solutions (CTSH) and Workday (WDAY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Cisco Systems (CSCO), Walmart (WMT), Raytheon (RTN), Mcdonald's (MCD), Honeywell International (HON), Northrop Grumman (NOC) and Visa (V).

Waters' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.36%), Fundsmith LLP (6.51%), Massachusetts Financial Services Co. MA (6.42%), Bank of New York Mellon Corp (5.83%), Baillie Gifford & Co. (3.32%) and Jensen Investment Management Inc. (1.39%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Nomura Asset Management Co. Ltd., Ownership Capital B.V., Bank of New York Mellon Corp, D. E. Shaw & Co. Inc., FMR LLC, Fundsmith LLP, Bessemer Group Inc. and Mackenzie Financial Corp. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, Elizabeth B Rae, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Bristol John W & Co. Inc. NY, Massachusetts Financial Services Co. MA, American Century Companies Inc., Nordea Investment Management AB, Citigroup Inc., Geode Capital Management LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $245.27.

Waters has a market capitalization of $17.54 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,246 workers across the globe.

The official website for Waters is http://www.waters.com.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]